Clinical Trials Browser

OTHER × Pancreatic Neoplasms × Docetaxel × Clear all

NCT02495896 2026-04-29

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Phase 1 Active not recruiting

GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms

NCT01905150 2024-12-11

Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

Phase 2 Completed

34 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01459614 2021-05-19

Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer

Phase 2 Completed

44 enrolled 12 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00066677 2021-03-05

Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Phase 2 Terminated

32 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00112697 2021-02-17

Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00276744 2018-10-24

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Phase 2 Terminated

249 enrolled 4 charts

Gastrointestinal

Pancreatic Neoplasms

NCT03668418 2018-09-12

xenoZ

Gastrointestinal

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT02450656 2018-08-27

M14AFS

Phase 1/2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02331251 2018-07-02

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

Phase 1/2 Terminated

BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT01888978 2018-04-09

Molecularly Tailored Therapy for Pancreas Cancer

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00426127 2017-12-29

Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer

Phase 2 Terminated

2 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00290693 2017-12-02

Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer

Phase 2 Completed

45 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00833859 2017-10-09

Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery

Phase 2 Terminated

2 enrolled 3 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00609336 2017-07-13

Perioperative Therapy for Resectable Pancreatic Cancer

Phase 2 Completed

35 enrolled 13 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00882310 2016-07-25

A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer

Phase 2 Completed

37 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00996333 2016-07-25

Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)

Phase 2 Completed

46 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00012220 2016-07-14

Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00320749 2016-06-27

Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer

Phase 1 Completed

21 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00869258 2016-06-22

Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar

Phase 2 Completed

32 enrolled 6 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01754623 2015-08-13

GTX-RT in Borderline Resectable Pancreatic Cancer

Phase 2 Terminated

9 enrolled 7 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00660699 2015-05-27

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

Phase 2 Completed

50 enrolled 21 charts

Gastrointestinal

Gallbladder Neoplasms, Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

NCT00238199 2015-04-24

Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00159471 2014-05-22

Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.

Phase NA Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT01065870 2014-01-29

Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)

Phase 2/3 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT00014456 2013-08-28

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Unknown Primary, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Stomach Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT00966706 2012-02-01

PACT-9

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00268840 2011-06-30

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT00049296 2010-06-11

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Phase 1 Completed

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

AIDS-related Kaposi sarcoma, Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Appendiceal Neoplasms, Astrocytoma, Bile Duct Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Chondrosarcoma, Colonic Neoplasms, Craniopharyngioma, Ependymoma, Esophageal Neoplasms, Gallbladder Neoplasms, Glioblastoma, Glioma, Carcinoma, Hepatocellular, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Medulloblastoma, Melanoma, Meningioma, Multiple Myeloma, Neoplasms, Neuroblastoma, Oligodendroglioma, Pancreatic Neoplasms, Pinealoma, Rectal Neoplasms, Salivary Gland Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Stomach Neoplasms, Urethral Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal Tumors, Primitive, Esthesioneuroblastoma, Olfactory, Glioma, Subependymal, Gliosarcoma, Lymphoma, B-Cell, Marginal Zone, Breast Neoplasms, Male, Lymphoma, Mantle-Cell, Gastrointestinal Stromal Tumors, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Small Cell Lung Carcinoma

NCT00761241 2010-05-26

Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00690300 2010-03-03

Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT00137761 2009-11-02

Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms